Conceptual frameworks of synthetic lethality in clear cell carcinoma of the ovary

Biomedical Reports
Hiroshi KobayashiSachiko Morioka

Abstract

Targeting non-oncogenes may result in the selective death of cancer cells. Clear cell carcinoma of the ovary (CCC) may exhibit resistance against conventional chemotherapy and is associated with poor prognosis. The aim of the present report was to review synthetic lethality-based therapies for CCC. Previous English-language studies were reviewed to accumulate preclinical and clinical data on targeting synthetic lethal partners. Synthetic lethal interactions have a variety of types, involving components of a backup or parallel pathway with overlapping functions, components encoded by paralogous pairs, subunit components that form heteromeric complexes and components that are arranged in a single linear pathway. A set of candidate gene targets potentially resulting in synthetic lethality have been previously identified. HNF class homeobox, AT-rich interaction domain 1A, ATR serine/threonine kinase, ATM serine/threonine kinase, checkpoint kinase 1 and phosphatase and tensin homolog may be the key partner genes. A variety of loss of function genes in CCC are driver or passenger events and may function as synthetic lethal pairs under replication stress conditions. Further clinical studies will be required to investigate the safety a...Continue Reading

References

Mar 16, 2001·Breast Cancer Research : BCR·R Scully
Oct 29, 2004·Nature Reviews. Cancer·Nicholas TurnerAlan Ashworth
Feb 16, 2005·Human Mutation·Yun WangAnne-Lise Børresen-Dale
Feb 16, 2010·The American Journal of Surgical Pathology·Robert J Kurman, Ie-Ming Shih
Oct 15, 2010·The New England Journal of Medicine·Kimberly C WiegandDavid G Huntsman
Oct 15, 2010·Science Translational Medicine·Konstantin J DedesJorge S Reis-Filho
Nov 3, 2010·Advances in Cancer Research·Joanne SmithDavid A Gillespie
May 10, 2011·Nature Structural & Molecular Biology·Luis I ToledoOscar Fernandez-Capetillo
Sep 20, 2011·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Emmanuele CrespanGiovanni Maga
Apr 14, 2012·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Nagahiro Saijo
Dec 24, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Hiroaki ItamochiTasuku Harada
Feb 5, 2014·Expert Opinion on Therapeutic Targets·João F S Carvalho, Roland Kanaar
Feb 13, 2014·Proceedings of the National Academy of Sciences of the United States of America·Gregory R HoffmanZainab Jagani
Mar 26, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Farr Reza NezhatSun-Wei Guo
May 9, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Hiroshi ShigetomiHiroshi Kobayashi
Jun 4, 2014·Cold Spring Harbor Perspectives in Medicine·David Dominguez-Sola, Jean Gautier
Jun 4, 2014·Journal of Medicinal Chemistry·Bingliang Fang
Sep 10, 2014·Cell Reports·Simona LambaAlberto Bardelli
Oct 7, 2014·OncoTargets and Therapy·Ying JinLingya Pan
May 13, 2015·Genetics and Molecular Research : GMR·Z G PengX Huang
Jul 1, 2015·Expert Opinion on Therapeutic Targets·Benjamin G BitlerRugang Zhang
Sep 10, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Junzo HamanishiIkuo Konishi
Nov 10, 2015·Chemistry & Biology·Gurushankar ChandramoulyRichard T Pomerantz
Dec 2, 2015·Oncology Letters·Hiroshi KobayashiChiharu Yoshimoto
Dec 2, 2015·Oncology Letters·Hiroshi KobayashiKazutoshi Nakano
Dec 18, 2015·Cancer Cell International·Shinya MatsuzakiTadashi Kimura
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Jan 11, 2016·Cell Reports·Kumar SanjivThomas Helleday
Mar 5, 2016·Current Treatment Options in Oncology·Fong W Liu, Krishnansu S Tewari
Aug 26, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wael JdeyMarie Dutreix
Sep 17, 2016·Journal of Translational Medicine·Anselmo PapaFederica Tomao
Oct 9, 2016·The New England Journal of Medicine·Mansoor R MirzaUNKNOWN ENGOT-OV16/NOVA Investigators
Nov 30, 2016·Current Opinion in Obstetrics & Gynecology·Paul T Kroeger, Ronny Drapkin
Dec 14, 2016·Nature Communications·Chris T WilliamsonChristopher J Lord
Jan 18, 2017·Pigment Cell & Melanoma Research·Nicola ThompsonMarco Ranzani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.

Related Papers

Pharmacology & Therapeutics
Anika Maria Weber, Anderson Joseph Ryan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Brent N RexerCarlos L Arteaga
© 2022 Meta ULC. All rights reserved